Skip To Main Content
Chong-Teik Lim on Muck Rack

Chong-Teik Lim

As seen in: Wiley Online Library, PLOS ONE
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chong-Teik

Contact Chong-Teik, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Integrative network pharmacology, transcriptomics, and molecular docking identify candidate Centella asiatica constituents and targets in neurodegenerative diseases

|
By Yuxi Xie, Chong-Teik Lim, Universiti Putra Malaysia
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Xie Y, Lim C-T, Lam X-J, Cheah P-S, Ling K-H, Huang T (2026) Integrative network pharmacology, transcriptomics, and molecular docking identify candidate Centella asiatica constituents and targets in neurodegenerative diseases. PLoS One 21(7): e0354882.
Open in Who Shared Issue with article?

Long‐term effectiveness and persistence rate of ustekinumab dose intensification in a South East Asian inflammatory bowel disease center

|
By Chong-Teik Lim, Shu-Wen Tay, Sakktivel Elangovan, Wan-Chee Ong
| Wiley Online Library Verified
Ustekinumab (UST) is an effective biologic for treatment of inflammatory bowel disease (IBD). However, some patients treated with UST have suboptimal clinical response with standard dosing. The aims of this study were to determine the effectiveness of UST dose intensification (DI), identify factors associated with DI, cumulative incidence of DI and persistence of UST among treated patients.
Open in Who Shared Issue with article?
See all 2 articles